During the past decade, Columbia University Medical Center, Department of Dermatology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Columbia University Medical Center, Department of Dermatology" #1 sponsor was "Columbia University" with 7 trials, followed by "Yaupon Therapeutics" with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Concert Pharmaceuticals" with 1 trials sponsored and "Julian M. Mackay-Wiggan" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia University Medical Center, Department of Dermatology" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Alopecia Areata Initiative - Gates Foundation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Locks of Love" with 1 trials as a collaborator and "Society for Pediatric Dermatology" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Columbia University Medical Center, Department of Dermatology" are "Alopecia Areata" (4 trials), "Atopic Dermatitis" (2 trials), "Mycosis Fungoides" (2 trials), "Acne Vulgaris" (1 trials) and "Brittle Nails" (1 trials). Many other conditions were trialed in "Columbia University Medical Center, Department of Dermatology" in a lesser frequency.

Most popular intervention types in "Columbia University Medical Center, Department of Dermatology" are "Drug" (8 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.04% Mechlorethamine gel" (1 trials), "ACZONE Gel, 5%" (1 trials), "Abatacept" (1 trials), "CTP-543, 12 mg BID" (1 trials) and "CTP-543, 8 mg BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbia University Medical Center, Department of Dermatology" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Columbia University Medical Center, Department of Dermatology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Columbia University Medical Center, Department of Dermatology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Columbia University Medical Center, Department of Dermatology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".